NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2031

Conditions
Anal Cancer
Interventions
DIAGNOSTIC_TEST

AMR B: HPV positive ctDNA guided imaging in follow-up

Blood samples in follow-up positive for ctDNA leads to an extra PET-CT scan to detect early treatment failure

Trial Locations (13)

2730

RECRUITING

Department of Oncology Herlev and Gentofte Hospital, Herlev

5021

NOT_YET_RECRUITING

Haukeland University Hospital, Bergen

7030

NOT_YET_RECRUITING

St. Olav's University Hospital, Trondheim

7100

RECRUITING

Department of Oncology, Vejle Hospital, Vejle

8000

RECRUITING

Aarhus University Hospital, Aarhus

9019

NOT_YET_RECRUITING

University Hospital of North Norway, Tromsø

20521

NOT_YET_RECRUITING

Turku University Hospital, Turku

33520

NOT_YET_RECRUITING

Tampere University Hospital, Tampere

0450

NOT_YET_RECRUITING

Oslo University Hospital, Oslo

413 45

NOT_YET_RECRUITING

Sahlgrenska University Hospital, Gothenburg

222 42

NOT_YET_RECRUITING

Skåne University Hospital Lund, Lund

171 64

NOT_YET_RECRUITING

Karonlinska University Hospital, Stockholm

907 37

NOT_YET_RECRUITING

Norrlands University Hospital, Umeå

All Listed Sponsors
collaborator

Danish Comprehensive Cancer Center

OTHER

collaborator

Nordic Cancer Union

OTHER

collaborator

The regions medicine- and treatment funds

UNKNOWN

lead

Aarhus University Hospital

OTHER